Topic Hub
14 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 14 of 14 clinical reviews.
A clinical guide to using Tresiba (insulin degludec) safely in geriatric patients, covering exercise timing, hypoglycemia risk, dose adjustments, and practical scheduling strategies for adults 65 and over.
Read clinical reviewA comprehensive clinical review of off-label insulin degludec (Tresiba) use in adolescents aged 12 to 17, covering trial data, dosing, safety, and ADA/ISPAD guideline context.
Read clinical reviewHow insulin degludec (Tresiba) affects older adults aged 65+: pharmacokinetics, hypoglycemia risk, dosing adjustments, cognitive considerations, and clinical trial data reviewed by the HealthRX medical team.
Read clinical reviewA comprehensive clinical guide to using Tresiba (insulin degludec) in patients aged 65 and older, covering dosing, hypoglycemia risk, titration strategies, off-label considerations, and evidence from key trials.
Read clinical reviewA clinical guide to transitioning older adults (65+) onto Tresiba (insulin degludec), covering dose adjustments, hypoglycemia risk, monitoring protocols, and ADA/AACE guideline recommendations.
Read clinical reviewA clinical guide to using Tresiba (insulin degludec) in children under 12 with type 1 diabetes, covering dosing, safety data, and the step-by-step process for transitioning young patients to adult endocrinology care.
Read clinical reviewA clinical deep-dive into off-label insulin degludec (Tresiba) use in children younger than 12, covering the evidence base, dosing considerations, safety data, and how it compares to approved basal insulins in this age group.
Read clinical reviewA clinical guide to transitioning adolescents with type 1 or type 2 diabetes on insulin degludec (Tresiba) from pediatric to adult care, covering dose adjustments, timing, monitoring, and what to expect.
Read clinical reviewA clinician-reviewed guide for caregivers and adolescent patients on administering Tresiba (insulin degludec) safely. Covers injection technique, dosing timing, storage, missed doses, and how to involve teens in self-management.
Read clinical reviewA practical clinical guide to managing insulin degludec (Tresiba) in adolescents aged 12 to 17, covering timing, physical activity, school accommodations, and hypoglycemia safety during the school day.
Read clinical reviewComplete caregiver guide for administering insulin degludec (Tresiba) to adults aged 65 and older: injection technique, hypoglycemia prevention, dose timing flexibility, storage, device options, and safety monitoring grounded in FDA labeling and ADA Standards of Care.
Read clinical reviewA clinical deep-dive into how insulin degludec (Tresiba) affects adolescents aged 12 to 17, covering glycemic control, growth, puberty, hypoglycemia risk, and practical dosing guidance backed by primary-source evidence.
Read clinical reviewComplete caregiver guide to administering insulin degludec (Tresiba) in children under 12: correct dosing steps, injection technique, storage, hypoglycemia management, and safety monitoring backed by FDA labeling and ADA pediatric standards.
Read clinical reviewA clinician-reviewed guide to how Tresiba (insulin degludec) affects growth, neurodevelopment, and glycemic control in children younger than 12, with trial data, dosing guidance, and safety considerations.
Read clinical review